Sho Saito

2.5k total citations
59 papers, 1.0k citations indexed

About

Sho Saito is a scholar working on Infectious Diseases, Neurology and Epidemiology. According to data from OpenAlex, Sho Saito has authored 59 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Infectious Diseases, 13 papers in Neurology and 10 papers in Epidemiology. Recurrent topics in Sho Saito's work include COVID-19 Clinical Research Studies (26 papers), SARS-CoV-2 and COVID-19 Research (14 papers) and Long-Term Effects of COVID-19 (13 papers). Sho Saito is often cited by papers focused on COVID-19 Clinical Research Studies (26 papers), SARS-CoV-2 and COVID-19 Research (14 papers) and Long-Term Effects of COVID-19 (13 papers). Sho Saito collaborates with scholars based in Japan, Belgium and United States. Sho Saito's co-authors include Masafumi Fujita, Kenichi Nishiyama, Masami Niwa, Kiichi Watanabe, Yoshiyuki Hirano, Minoru Onozuka, Norio Ohmagari, Kayoko Hayakawa, Shinya Tsuzuki and Mari Terada and has published in prestigious journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Sho Saito

54 papers receiving 997 citations

Peers

Countries citing papers authored by Sho Saito

Since Specialization

Citations

This map shows the geographic impact of Sho Saito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sho Saito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sho Saito more than expected).

Fields of papers citing papers by Sho Saito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sho Saito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sho Saito. The network helps show where Sho Saito may publish in the future.

Co-authorship network of co-authors of Sho Saito

This figure shows the co-authorship network connecting the top 25 collaborators of Sho Saito. A scholar is included among the top collaborators of Sho Saito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sho Saito. Sho Saito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Time from Admission to the Onset of Methicillin-Resistant <i>Staphylococcus aureus</i> Bacteremia in a Single Acute Care Hospital in Japan 2024 ·Japanese Journal of Infectious Diseases ·(unknown), Shinya Tsuzuki, (unknown), Sho Saito, (unknown)	1
2	COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production 2024 ·BMC Infectious Diseases ·Takato Nakamoto, Noriko Iwamoto, (unknown), (unknown), (unknown), (unknown), Keiji Nakamura, Hidetoshi Nomoto, Yutaro Akiyama, Tetsuya Suzuki, Yusuke Miyazato, Michiyo Suzuki, Kumiko Suzuki, Moto Kimura, Sho Saito, Satoshi Kutsuna, Norio Ohmagari	0
3	Efficacy and Safety of the Smallpox Vaccine for Postexposure Prophylaxis in Monkeypox: Protocol for an Open-Labeled, Single-Armed Study 2023 ·JMIR Research Protocols ·(unknown), Junko Terada-Hirashima, Yukari Uemura, Noriko Tomita, Yosuke Shimizu, (unknown), (unknown), Tetsuya Suzuki, Sho Saito, Mugen Ujiie, Wataru Sugiura, Norio Ohmagari	4
4	Protocol of Tecopox study: a multicentre, open-label, double-arm trial to evaluate the efficacy and safety of oral tecovirimat therapy for patients with smallpox or monkeypox 2023 ·BMJ Open ·Tetsuya Suzuki, Sho Saito, Shinya Tsuzuki, (unknown), (unknown), Tomoki Yoshikawa, Masayuki Shimojima, Hideki Ebihara, Norio Ohmagari, Shinichiro Morioka	4
5	An open-label, non-randomized study investigating the safety and efficacy of smallpox vaccine, LC16, as post-exposure prophylaxis for mpox 2023 ·Human Vaccines & Immunotherapeutics ·Noriko Tomita, Junko Terada-Hirashima, Yukari Uemura, Yosuke Shimizu, (unknown), (unknown), Tetsuya Suzuki, Sho Saito, (unknown), Wataru Sugiura, Norio Ohmagari, Mugen Ujiie	11
6	Nasopharyngeal SARS-CoV-2 may not be dispersed by a high-flow nasal cannula 2023 ·Scientific Reports ·Tetsuya Suzuki, Shinichiro Morioka, Kei Yamamoto, Sho Saito, Shun Iida, Katsuji Teruya, Jin Takasaki, Masayuki Hojo, Kayoko Hayakawa, Satoshi Kutsuna, Shô Miyamoto, Seiya Ozono, Tadaki Suzuki, Eiichi Kodama, Norio Ohmagari	2
7	Predictive model of risk factors of High Flow Nasal Cannula using machine learning in COVID-19 2022 ·Infectious Disease Modelling ·Nobuaki Matsunaga, (unknown), Yusuke Asai, Shinya Tsuzuki, Yasuaki Sakamoto, (unknown), Takayuki Akiyama, (unknown), Gen Yamada, Mari Terada, Setsuko Suzuki, Kumiko Suzuki, Sho Saito, Kayoko Hayakawa, Norio Ohmagari	4
8	Neutralising activity and antibody titre in 10 patients with breakthrough infections of the SARS-CoV-2 Omicron variant in Japan 2022 ·Journal of Infection and Chemotherapy ·(unknown), Shinya Tsuzuki, Sho Saito, Shin-ichiro Hattori, Junko S. Takeuchi, Tomoya Saito, Mugen Ujiie, Masayuki Hojo, Noriko Iwamoto, Wataru Sugiura, Hiroaki Mitsuya, Norio Ohmagari	1
9	We Should Pay More Attention to Sex Differences to Predict the Risk of Severe COVID-19: Men Have the Same Risk of Worse Prognosis as Women More Than 10 Years Older 2022 ·Journal of Epidemiology ·Yumi Matsushita, Tetsuji Yokoyama, Kayoko Hayakawa, Nobuaki Matsunaga, Hiroshi Ohtsu, Sho Saito, Mari Terada, Setsuko Suzuki, Shinichiro Morioka, Satoshi Kutsuna, Shinya Tsuzuki, Hisao Hara, Akio Kimura, Norio Ohmagari	1
10	Factors associated with development and persistence of post-COVID conditions: A cross-sectional study 2022 ·Journal of Infection and Chemotherapy ·Yusuke Miyazato, Shinya Tsuzuki, Shinichiro Morioka, Mari Terada, Satoshi Kutsuna, Sho Saito, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Keiko Tanaka, Michiyo Suzuki, Kayoko Hayakawa, Norio Ohmagari	16
11	Factors Associated With Prolonged Psychological Distress Among Nurses and Physicians Engaged in COVID-19 Patient Care in Singapore and Japan 2022 ·Frontiers in Psychiatry ·Shinichiro Morioka, Ban Hock Tan, Hiroe Kikuchi, Yusuke Asai, Tetsuya Suzuki, (unknown), Satoshi Kutsuna, Sho Saito, Kayoko Hayakawa, Thuan Tong Tan, Eiichi Kodama, Norio Ohmagari	6
12	Antibody titers and neutralizing activity in cases of COVID-19 after a single dose of vaccination 2022 ·Journal of Infection and Chemotherapy ·(unknown), Sho Saito, Yuki Takamatsu, Junko S. Takeuchi, Yusuke Asai, (unknown), Noriko Iwamoto, Kenji Maeda, Hiroaki Mitsuya, Norio Ohmagari	1
13	Risk factors associated with asymptomatic hypoxemia among COVID-19 patients: a retrospective study using the nationwide Japanese registry, COVIREGI-JP 2022 ·Journal of Infection and Public Health ·Yutaro Akiyama, Shinichiro Morioka, Yusuke Asai, (unknown), Setsuko Suzuki, Sho Saito, Nobuaki Matsunaga, Kayoko Hayakawa, Norio Ohmagari	2
14	No SARS-CoV-2 RNA detected in the convalescent plasma of COVID-19 patients with different disease severity 2021 ·Journal of Infection and Chemotherapy ·Hidetoshi Nomoto, Satoshi Kutsuna, Kazu Okuma, Madoka Kuramitsu, Kenta Tezuka, (unknown), Sho Saito, Noriko Kinoshita, Mari Terada, Mio Endo, Tetsuya Suzuki, Yusuke Miyazato, Takato Nakamoto, (unknown), Isao Hamaguchi, Norio Ohmagari	2
15	Clinical course of alopecia after COVID-19 2021 ·International Journal of Infectious Diseases ·Tetsuya Suzuki, Satoshi Kutsuna, Sho Saito, Akira Kawashima, (unknown), (unknown), (unknown), (unknown), Yutaro Akiyama, Satoshi Ide, Keiji Nakamura, Takato Nakamoto, Kei Yamamoto, Masahiro Ishikane, Noriko Kinoshita, Shinichiro Morioka, Kayoko Hayakawa, Norio Ohmagari	6
16	Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation 2021 ·Epidemiology and Infection ·Gen Yamada, Kayoko Hayakawa, Nobuaki Matsunaga, Mari Terada, Setsuko Suzuki, Yusuke Asai, Hiroshi Ohtsu, (unknown), Koji Kitajima, Shinya Tsuzuki, Sho Saito, Norio Ohmagari	11
17	Possibility of transmission of severe acute respiratory syndrome coronavirus 2 in a tertiary care hospital setting: A case study 2020 ·Infection Prevention in Practice ·Shinichiro Morioka, Keiji Nakamura, Shun Iida, Satoshi Kutsuna, Noriko Kinoshita, Tetsuya Suzuki, Tadaki Suzuki, Kei Yamamoto, Kayoko Hayakawa, Sho Saito, Norio Ohmagari	4
18	<b>Attempt to Develop Japanese Translation of “NIH and FDA Release Protocol Template for Phase 2 and 3 IND/IDE Clinical Trials” </b> 2018 ·Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics ·Masao Kobayakawa, Mari Terada, Hiroshi Ohtsu, Kazuo Izumi, Sho Saito, (unknown), Hiroshi Watanabe	0
19	Intravenous to oral switch therapy in cancer patients with catheter-related bloodstream infection due to methicillin-sensitive Staphylococcus aureus: A single-center retrospective observational study 2018 ·PLoS ONE ·Naoya Itoh, Yoshiro Hadano, Sho Saito, (unknown), (unknown), Hanako Kurai	10
20	[Basic and clinical studies on biapenem (L-627) in obstetrics and gynecology]. 1994 ·PubMed ·Seiji Matsuda, (unknown), Shigeru Ando, (unknown), Takahiro Shimizu, (unknown), Kazuo Sengoku, Sho Saito, S Shibata, Henning Andreas Haga	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact